Prognostic value of patient-reported symptom interference in patients with late-stage lung cancer

Relationship Between Deficits in Overall Quality of Life and Non–Small-Cell Lung Cancer Survival

(2012) Jeff A. Sloan et al.   JOURNAL OF CLINICAL ONCOLOGY

Quality of life assessment as a predictor of survival in non-small cell lung cancer

(2011) Donald P Braun et al.   BMC CANCER

The impact of symptom interference using the MD Anderson Symptom Inventory-Brain Tumor Module (MDASI-BT) on prediction of recurrence in primary brain tumor patients

(2011) Terri S. Armstrong et al.   CANCER

Electronic Toxicity Monitoring and Patient-Reported Outcomes

(2011) Ethan M. Basch et al.   CANCER JOURNAL

Levels of Symptom Burden During Chemotherapy for Advanced Lung Cancer: Differences Between Public Hospitals and a Tertiary Cancer Center

(2011) Charles S. Cleeland et al.   JOURNAL OF CLINICAL ONCOLOGY

Measuring the Symptom Burden of Lung Cancer: The Validity and Utility of the Lung Cancer Module of the M. D. Anderson Symptom Inventory

(2011) T. R. Mendoza et al.   ONCOLOGIST

The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008

(2010) David Cella et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients

(2009) Sook Ryun Park et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials

(2009) Chantal Quinten et al.   LANCET ONCOLOGY

The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

(2008) Carolyn C. Gotay et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic factor analysis of health-related quality of life data in cancer: a statistical methodological evaluation

(2008) ME Mauer et al.   Expert Review of Pharmacoeconomics & Outcomes Research